Literature DB >> 12481144

Renal replacement in end-stage renal disease patients over 75 years old.

I Létourneau1, D Ouimet, M Dumont, V Pichette, M Leblanc.   

Abstract

BACKGROUND: Over the last decade, the age of dialysis patients has been increasing steadily in several units in Canada. Our main objective was to assess prevalence, co-morbidity and outcome of ESRD patients over 75 years old at the beginning of dialysis treatment in our center. As a group, they were compared to younger dialysis patients treated simultaneously.
METHODS: In the last 5 years, all cases beginning dialysis in our institution who were above 75 years of age were reviewed, as well as cases aged between 50 and 60 years who started dialysis during the same period. Between January 1996 and December 2000, among a total of 429 new chronic dialysis patients, 67 ESRD patients over 75 years (15.6%) and 66 patients between 50 and 60 years (15.4%) began dialysis treatment. RESULTS--PRIMARY AND SECONDARY: Diabetes was present in 37% of elderly and in 56% of the younger patients. Younger patients had been referred earlier to our nephrologists than the older ones (42 vs. 27%). Elderly were more frequently treated by hemodialysis than peritoneal dialysis (81 vs. 19%) when compared to their younger counterparts (65 vs. 35%). Long-term catheters for hemodialysis were used more often in elderly patients. No renal transplantation were performed in older patients while 7 younger patients received a renal graft. Survival rates after 1 and 3 years were, respectively, 93 and 74% for patients between 50 and 60 years, whereas it decreased to 80 and 45% for those over 75 years (p = 0.002). More than 50% of patients older than 75 years died within 2 years after starting dialysis; their mean survival was 31 months; patients starting dialysis between 50 and 60 years survived on the average 44 months during the study period. According to the multivariate logistic regression model, risk factors for increased mortality in the older group were: number of hospitalization days during the past 3 months (OR 34.8, 95% CI 8.3-145.7, p < 0.001) and lower weight (OR 16.6, 95% CI 2.0-139.0, p = 0.001).
CONCLUSION: We may conclude that, in our hands, life expectancy of patients who began dialysis above 75 years is significantly shorter than for patients for whom dialysis is initiated between age 50 and 60 years, especially if they have a low weight, lose weight and/or require hospitalization. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12481144     DOI: 10.1159/000068040

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  16 in total

1.  It is not polite to ask a dialysis patient his age!

Authors:  Anuja Shah; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  Int Urol Nephrol       Date:  2011-05-06       Impact factor: 2.370

2.  Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors.

Authors:  Daniel Canter; Alexander Kutikov; Mohit Sirohi; Ryan Street; Rosalia Viterbo; David Y T Chen; Richard E Greenberg; Robert G Uzzo
Journal:  Urology       Date:  2011-02-12       Impact factor: 2.649

3.  Outcomes of arteriovenous fistula creation after the Fistula First Initiative.

Authors:  Carrie A Schinstock; Robert C Albright; Amy W Williams; John J Dillon; Eric J Bergstralh; Bernice M Jenson; James T McCarthy; Karl A Nath
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

4.  Chronic peritoneal dialysis in the tenth decade of life.

Authors:  Sham Sunder; Hulya Taskapan; Jaime Jojoa; Murali Krishnan; Mukesh Khandelwal; Sharron Izatt; Maggie Chu; Padmanabhan Subramanian; Hithaishi Chinthalapalli; Thierry Lobbedez; Saribjit Vanita Jassal; Joanne M Bargman; Dimitros G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

5.  Atherosclerotic risk factors and carotid stiffness in elderly asymptomatic HD patients.

Authors:  Paraskevi Tseke; Eirini Grapsa; Kimon Stamatelopoulos; Elisabeth Samouilidou; Athanasios Protogerou; Christos Papamichael; Antonios Laggouranis
Journal:  Int Urol Nephrol       Date:  2006-11-07       Impact factor: 2.370

Review 6.  Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature.

Authors:  Carlos G Musso; Konstantina Trigka; Periklis Dousdampanis; Jose Jauregui
Journal:  Int Urol Nephrol       Date:  2014-12-05       Impact factor: 2.370

7.  Induction immunosuppression in kidney transplant recipients older than 60 years of age : safety and efficacy of ATGAM, OKT3 and Simulect.

Authors:  Michael Heifets; Muhammad I Saeed; Mitten H Parikh; Debra Sierka; Mysore S A Kumar
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 8.  Functional and Cognitive Impairment, Frailty, and Adverse Health Outcomes in Older Patients Reaching ESRD-A Systematic Review.

Authors:  Marije H Kallenberg; Hilda A Kleinveld; Friedo W Dekker; Barbara C van Munster; Ton J Rabelink; Marjolijn van Buren; Simon P Mooijaart
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-24       Impact factor: 8.237

Review 9.  Quality of life in the elderly patients on dialysis.

Authors:  Theofanis Apostolou
Journal:  Int Urol Nephrol       Date:  2007-05-24       Impact factor: 2.370

10.  Hemodialysis in patients older than 65 years with end-stage renal failure--comparison of outcome in patients with and without diabetes.

Authors:  Herwig Pieringer; Georg Biesenbach
Journal:  Z Gerontol Geriatr       Date:  2008-03-11       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.